About Phagenesis Ltd
Retrain The Brain. Restore Swallowing Control.
- Industry
- Medical Device
- Company size
- 51-200 employees
- Headquarters
- Manchester
- Founded
- 2007
- Company type
- Privately Held
Phagenyx® is the first and only clinically validated neuromodulation system that utilizes pharyngeal electrical stimulation (PES) to improve swallowing safety and efficiency to accelerate recovery from post-stroke dysphagia. Supported by 30+ publications and designed for real-world care, Phagenyx enables early intervention, resulting in a 6-day faster return to oral nutrition, >2x improvement in swallowing safety, and 8 fewer days in the hospital.
Specialties
- Dysphagia treatment
- Stroke rehabilitation
- neurocritical care
- neurostimulation
- dysphagia
- SpeechLanguagePathology
- neuroscience
- neurology
- stroke
- and speechlanguagetherapy
Company locations
Enterprise House, Manchester, M15 6SE, GB
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- People linked to this company
- 80
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.